Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study)

NCT00696774 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00696774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00696774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study)
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2008
Completion date
July 31, 2009
Enrollment
242 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major